1. Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant patients;Awni;Transplant. Proc.,1990
2. Physiologic modeling of cyclosporin kinetics in rat and man;Bernareggi;J. Pharmacokinet. Biopharm.,1991
3. Body distribution in mice of intravenously injected radiolabelled cyclosporin associated with polyisohexylcyanoacrylate nanocapsules or nanospheres;Bonduelle;Eur. J. Pharm. Biopharm.,1995
4. Selective suppression of rat hepatic microsomal activity during chronic cyclosporine nephrotoxicity;Brunner;J. Pharm. Exp. Ther.,1996
5. Cyclosporin clinical pharmacokinetics;Fahr;Clin. Pharmacokinet.,1993